DAVIS STEPHEN

CIK 00011311466 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001131146

Recent Transactions

46 trades

Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-19$15.28/sh−31,747→ 186,555 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+17,333→ 173,520 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+44,782→ 218,302 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-02$16.94/sh−11,427→ 155,231 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-01+22,391→ 166,658 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-01−22,391→ 67,173 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−17,716→ 144,267 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−8,858→ 161,983 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+34,666→ 170,841 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−17,333→ 34,667 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−34,666→ 138,666 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+17,333→ 136,175 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-27$17.90/sh−17,714→ 118,842 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-25+34,666→ 136,556 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2024-03-25+286,451→ 286,451 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-26$24.67/sh−5,577→ 101,890 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-23+10,946→ 107,467 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-02-23−10,946→ 10,946 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-08$29.96/sh−3,732→ 96,521 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-01-06−9,528→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-06+9,528→ 100,253 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-24$18.78/sh−3,851→ 91,727 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-02-23−10,945→ 21,892 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-23+10,945→ 95,578 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2020-04-30$49.21/sh−6,770→ 11,809 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2020-04-29−15,625→ 46,875 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2020-04-29+15,625→ 18,579 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (right to buy)
2018-04-18+135,000→ 135,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-07-13+20,000→ 20,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-07-13+9,167→ 9,167 total
Award
HERON THERAPEUTICS, INC. /DE/$HRTX
Stock Option (right to buy)
2014-01-03+1,066,667→ 1,066,667 total
Award
SYNAGEVA BIOPHARMA CORP
Stock Option (Right to Buy)
2012-06-27+7,500→ 7,500 total
Tax Payment
Ardea Biosciences, Inc./DE
Common Stock
2012-01-06$15.55/sh−218→ 16,922 total
Sale
Ardea Biosciences, Inc./DE
Common Stock
2012-01-06$15.91/sh−700→ 16,222 total
Tax Payment
Ardea Biosciences, Inc./DE
Common Stock
2011-06-06$23.94/sh−192→ 19,542 total
Sale
Ardea Biosciences, Inc./DE
Common Stock
2010-11-22$21.92/sh−351→ 25,117 total
Award
SYNAGEVA BIOPHARMA CORP
Nonqualified Stock Option (right to buy)
2007-08-14−15,000→ 15,000 total
Award
SYNAGEVA BIOPHARMA CORP
Nonqualified Stock Option (right to buy)
2007-06-27$6.84/sh+20,000→ 20,000 total
Award
NEUROGEN CORP
Common Stock
2004-12-22$9.15/sh+487→ 5,979 total
Exercise/Conversion
NEUROGEN CORP
Common Stock
2004-12-21$3.87/sh+17,488→ 0 total
Sale
NEUROGEN CORP
Common Stock
2004-12-21$9.00/sh−17,488→ 0 total
Award
NEUROGEN CORP
Stock Option (Right to Buy)
2004-12-21+100,000→ 100,000 total
Exercise/Conversion
NEUROGEN CORP
Common Stock
2004-12-21$3.87/sh+12→ 0 total
Exercise/Conversion
NEUROGEN CORP
Stock Option (Right to Buy)
2004-12-21−12→ 0 total
Exercise/Conversion
NEUROGEN CORP
Stock Option (Right to Buy)
2004-12-21−17,488→ 0 total
Sale
NEUROGEN CORP
Common Stock
2004-12-21$9.55/sh−12→ 50,750 total

Companies

Recent Filings

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130

View on SEC.gov